Cosmetic and/or dermatological use of a composition containing at least one oxidation-sensitive hydrophilic active principle stabilized by at least one maleic anhydride copolymer
A technology of maleic anhydride, active ingredients, applied in drug combination, skin diseases, emulsion delivery, etc., can solve problems such as lack of freshness
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0086] Example 1: Accelerated storage test
[0087] The purpose of this test is to investigate the decomposition of oxidation-sensitive hydrophilic active ingredients after storage at 45°C for 2 months. Various solutions were prepared and their compositions are shown in the table below:
[0088] combination
[0089] The whole solution was adjusted to pH 6 with 8.9 mol / l KOH.
[0090] The percentages of polymer are based on active matter.
[0091] Polymer 1 : Styrene / maleic anhydride (50 / 50) copolymer in the form of 30% ammonium salt in water, by Atofina under the reference name SMA1000H for sale.
[0092] Polymer 2 : Styrene / maleic anhydride (50 / 50) copolymer, in the form of the sodium salt, manufactured by Atofina under the reference name SMA1000HNa for sale.
[0093] The degree of decomposition determined is expressed in the following scale:
[0094] (C 0 -C 2个月 ) / C 0
[0095] and there is C of ascorbic acid at t=0 0 Concentrati...
Embodiment 2
[0105] Example 2: The addition of the combination form of the present invention has an effect on the synthesis of tenascin and collagen VII. Observations of the resulting effects
[0106] This example describes the immunohistochemical labeling of proteins with tenascin and collagen VII by microscopic observation of skin sections, the effect of the addition of a combination of the invention (comprising ascorbic acid and a copolymer of the invention) on reconstituted skin.
[0107] 1. Preparation of Reconstituted Skin
[0108] The reconstituted skin used was prepared according to the protocol described by Asselineau et al. (Models in Dermato. Published by Loire and Maibach, 1987, Vol III, 1-7). Improvements to this scheme are described below:
[0109] -Normal adult skin fibroblasts per equivalent dermis 10 6 The proportion of cells used;
[0110] - The inoculation of keratinocytes is carried out at a ratio of 50 000 cells per ring with a diameter of 1.5 cm. The keratin...
Embodiment 3
[0123] Example 3: O / W Anti-Aging Cream
[0124] The following compositions were prepared in a manner conventional to those skilled in the art.
[0125] Phase A
[0126] Water 18.33g
[0127] Glycerin 3g
[0128] Phase B
[0129] Sorbitan Tristearate 0.68g
[0130] PEG-40 Stearate 1.5g
[0131] Cetyl Alcohol 3g
[0132] Glyceryl Stearate 2.25g
[0133] Myristyl myristate 1.5g
[0134] Ethylhexyl Palmitate 1.5g
[0135] Hydrogenated polyisobutylene 2.5g
[0136] Shorea robusta seed butter 1.5g
[0137] Shea (butyrospermum parkii) (shea butter) fruit 0.5g
[0138] Cyclopentasiloxane 7.5g
[0139] Phenoxyethanol 1g
[0140] Phase C
[0141] Water 43.94g
[0142] Ascorbic acid 5g
[0143] Potassium hydroxide (50% solution) 3g
[0144] Styrene / maleic anhydride copolymer, 30% ammonium salt in water 3.3g
[0145] (SMA1000H , Atofina)
[0146] A thick and soft cream is obtained that combats the signs of aging, in which ascorbic acid has good stability over time. ...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More - R&D
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com